Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDalata Hotel Gp Regulatory News (DAL)

Share Price Information for Dalata Hotel Gp (DAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 347.00
Bid: 334.00
Ask: 360.00
Change: 3.00 (0.87%)
Spread: 26.00 (7.784%)
Open: 344.00
High: 0.00
Low: 0.00
Prev. Close: 344.00
DAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

First Day of Dealings

19 Mar 2014 07:00

RNS Number : 4073C
Dalata Hotel Group PLC
19 March 2014
 



19 March 2014

 

 

DALATA HOTEL GROUP PLC

FIRST DAY OF DEALINGS

 

Dalata Hotel Group p.l.c. ("Dalata" or the "Company"), the largest hotel operator in Ireland, is pleased to announce that admission takes place and dealings in its ordinary shares commence at 8.00 a.m. today on the AIM Market of the London Stock Exchange, under the ticker DAL and on the ESM Market of the Irish Stock Exchange, under the ticker DHG.

 

For further information, please contact:

 

 

Davy Corporate Finance Tel: +353 (0)1 679 6363

Ronan Godfrey

Brian Ross

Anthony Farrell

 

 

Davy Corporate Broking

Paul Burke Tel: +353 (0)1 679 7788

Niall Jones

 

 

PR Adviser

Padraig McKeon Tel: + 353 (0) 87 231 2632

 

COMPANY OVERVIEW 

Dalata is the largest hotel operator in Ireland, operating 40 hotels with over 6,100 rooms. All of the hotels in the Group's portfolio are located in Ireland, other than the Maldron Hotel Cardiff. Dalata operates 12 hotels under lease agreements, 1 hotel under a long term operating agreement and 27 hotels under short term management agreements.

The Board of Dalata is made up 3 executive directors and 4 non-executive directors namely John Hennessy (Non-executive chairman), Pat McCann (Chief Executive), Dermot Crowley (Deputy Chief Executive, Finance & Development), Stephen McNally (Deputy Chief Executive) and non-executive directors Alf Smiddy, Margaret Sweeney, and Robert Dix.

Dalata' strategy is to acquire 3 and 4 star hotels and leverage its core hotel operational competencies and significant economies of scale to maximise the financial performance of its growing prortfolio. Dalata will also look for hotel development opportunities in the undersupplied Dublin market

In addition, the Group plans to continue to provide hotel management solutions to third party hotels under both lease and management agreements. The Group has taken over the operation of 8 additional hotels since the start of 2014.

For the year ended 31 December 2013 the Dalata Group had revenue of €60.6 million (2012: €54.1 million) and EBITDA of €5.3 million (2012: €3.5 million). The Company has a number of notable attributes:

ENDS

IMPORTANT NOTICES

 

The contents of this announcement, which have been prepared by and are the sole responsibility of the Company, have been approved by Davy solely for the purposes of section 21(2) (b) of the Financial Services and Markets Act 2000, as amended ("FSMA").

 

This announcement is an advertisement and not an admission document or a prospectus and investors should not subscribe for or purchase any shares referred to in this announcement except solely on the basis of information in the Admission Document to be published by the Company in due course in connection with the Placing and the Admission of Shares to trading on ESM and AIM ("the Admission").

 

The distribution or publication of this announcement, any related documents, and other information in connection with the Admission and Placing may be restricted by law in certain jurisdictions and persons into whose possession this announcement or any document or other information referred to herein are required to inform themselves about, and observe, any such restrictions. Any failure to comply with these restrictions may constitute a violation of the securities laws of such jurisdictions.

 

Neither this announcement nor any copy of it and the other documents or other information relating to the Admission and Placing may be taken or transmitted into the United States, Australia, Canada or Japan or the Republic of South Africa or to a resident, national or citizen of the United States, Canada, Australia, Japan or the Republic of South Africa. Any failure to comply with these restrictions may constitute a violation of the securities laws of such jurisdictions.

 

This announcement does not constitute, or form part of, and should not be construed as, an offer for sale or subscription or solicitation of or invitation to make any offer to buy or subscribe for any securities. Neither this announcement nor any part of it shall from the basis of or be relied on in connection with or act as an inducement to enter into any contract or commitment whatsoever. The information in this announcement is for background purposes only and does not purport to be full or complete. No reliance may or should be placed by any person for any purposes whatsoever on the information contained in this announcement or on its completeness, accuracy or fairness. The information in this announcement is subject to change.

 

The Shares have not been and will not be registered under the US Securities Act of 1933, as amended (the 'Securities Act') or under any securities laws of any state or other jurisdiction of the United States or under the applicable securities law of Australia, Canada, Japan or the Republic of South Africa. The Shares may be offered or sold in the United States or to, or for the account or benefit, of, US persons (as defined in Regulation S under the Securities Act) only in a transaction registered under the Securities Act in a transaction exempt from or not subject to the registration requirements of the Securities Act and in compliance with any applicable state securities laws. The Shares, subject to certain exceptions, may not be offered or sold, directly or indirectly, in or into Australia, Canada, Japan or the Republic of South Africa or to or for the account or benefit, of, any national resident or citizen of such countries. There will be no public offering of the Shares.

 

This announcement is being distributed only to, and is directed at (i) persons in member states of the European Economic Area ("Member States") who are a "Professional Client / Eligible Counterpart" within the meaning of Annex II/Articles 24(2) of MiFID (Directive 2004/39/EC as amended). In addition, this document is only directed at and being distributed: (A) in the United Kingdom, to persons (i) who have professional experience in matters relating to investments and who fall within the definition of "investment professionals" in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) (the "Order") or (ii) who fall within Article 49 of the Order; (B) in Ireland to qualified investors who are a "Professional Client / Eligible Counterpart" as defined in the European Communities (Markets in Financial Instruments) Regulations 2007; and (C) any other persons to whom it may otherwise be lawfully communicated (together all such persons being referred to as "relevant persons"). The investment or investment activity to which this document relates is available only to such persons. Any person who is not a relevant person should not act or rely on this announcement or any of its contents. It is not intended that this announcement be distributed or passed on, directly or indirectly, to any other class of person and in any event and under no circumstances should persons of any other description rely on or act upon the contents of this document. This announcement is being supplied solely for information and may not be reproduced by, further distributed or published in whole or in part by, any other person. By receiving this document you are deemed to warrant to the Company and Davy that you fall within the categories described above and agree to and will comply with the contents of this notice.

 

This announcement may include statements that are, or may be deemed to be "forward-looking statements". These forward-looking statements may be identified by the use of forward-looking terminology, including the terms "believes", "estimates", "plans", "projects", "anticipates", "expects", "intends", "may", "will", "could", or "should" or, in each case, their negative or other variations or comparable terminology, including references to assumptions, or by discussions of strategy, plans, objectives, goals, future events or intentions. Forward-looking statements may and often do differ materially from actual results. Any forward-looking statement reflect the Company's current view with respect to future events and are subject to risks relating to future events and other risks, uncertainties and assumptions relating to the Group's business, results of operations, financial position, liquidity, prospects, growth and strategies. Forward-looking statements speak only as of the date they are made. Subject to any legal or regulatory requirements, the Company expressly disclaims any obligation or undertaking to disseminate any updates or revisions to any forward-looking statements contained in this announcement to reflect any changes in Company's expectations with regard thereto or any change in events, conditions or circumstance on which any such statement is based. Information in this announcement, past performance or any of the documents relation to the Placing, Admission and/or the Shares cannot be relied upon as a guide to future performance.

 

Davy, which is regulated in Ireland by the Central Bank of Ireland, is acting exclusively for the Company in relation to the Placing and Admission and will not regard any other person as its client in relation to the Placing or Admission and will not be responsible to any person other than the Company for providing the protections afforded to its clients or for advising any other person in relation to the Placing or Admission or any transaction or arrangement referred to or information contained in this announcement.

 

None of the Company, Davy or any of their respective affiliates, their respective directors, officers, partners, employees, advisers or agents or advisers of any other person acting on their behalf, accepts any responsibility or liability whatsoever for, or makes any representation or warranty, express or implied, as to the truth, accuracy, completeness or fairness of the information or opinions contained in, in this announcement (or whether any information has been omitted from this announcement) or of any other information relating to the Company, its subsidiaries or associated companies, whether written, oral or in a visual or electronic form, and howsoever transmitted or made available. Accordingly the Company and Davy and of their respective affiliates, their respective directors, officers, partners, employees, advisers or agents or advisers of any other person acting on their behalf expressly disclaims any and all liability whatsoever for any loss arising from or in reliance upon the whole or part of the contents of this announcement, whether in tort, contract or otherwise which they otherwise have in respect of this announcement its contents or otherwise.

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAFDLFAFLEAF
Date   Source Headline
20th Mar 20183:55 pmRNSHolding(s) in Company
12th Mar 20183:51 pmRNSDirector/PDMR Shareholding
1st Mar 20181:34 pmRNSTotal Voting Rights
27th Feb 20187:00 amRNSFinal Results
12th Feb 20187:45 amRNSHolding(s) in Company
2nd Feb 20183:40 pmRNSHolding(s) in Company
1st Feb 201810:41 amRNSTotal Voting Rights
12th Jan 20187:00 amRNSNotice of Results
2nd Jan 20189:14 amRNSTotal Voting Rights
27th Dec 20177:00 amRNSHolding(s) in Company
21st Dec 20173:26 pmRNSHolding(s) in Company
19th Dec 20177:00 amRNSYear End Trading Update
7th Dec 20175:52 pmRNSHolding(s) in Company
6th Dec 20173:44 pmRNSHolding(s) in Company
5th Dec 201711:40 amRNSTotal Voting Rights
29th Nov 20175:13 pmRNSHolding(s) in Company
22nd Nov 20174:58 pmRNSAgreement
7th Nov 201710:15 amRNSSigned A New Lease Agreement
7th Nov 20177:00 amRNSCapital Markets Day
1st Nov 20179:44 amRNSTotal Voting Rights
25th Oct 20173:42 pmRNSHolding(s) in Company
4th Oct 20174:32 pmRNSHolding(s) in Company
2nd Oct 20179:56 amRNSTotal Voting Rights
29th Sep 20174:58 pmRNSHolding(s) in Company
29th Sep 20174:10 pmRNSAcquisition
27th Sep 20174:16 pmRNSHolding(s) in Company
27th Sep 20173:49 pmRNSHolding(s) in Company
19th Sep 20178:28 amRNSHolding(s) in Company
18th Sep 20177:00 amRNS33 Suites in Clarion Hotel Liffey Valley
13th Sep 20178:51 amRNSHolding(s) in Company
5th Sep 20172:32 pmRNSDirector/PDMR Shareholding
5th Sep 20177:00 amRNSHalf-year Report
1st Sep 20177:57 amRNSTotal Voting Rights
29th Aug 201712:54 pmRNSAcquisition Update
11th Aug 20173:18 pmRNSSale & Leaseback of Hotel La Tour (Birmingham)
3rd Aug 20177:00 amRNSNotice of Results
31st Jul 201710:12 amRNSTotal Voting Rights
21st Jul 20171:56 pmRNSDalata Acquires Hotel La Tour (Birmingham) Ltd
18th Jul 20177:00 amRNSPlanning Application for Tara Towers Site
3rd Jul 20177:02 amRNSDalata Sells Leasehold Interest
30th Jun 20179:48 amRNSTotal Voting Rights
28th Jun 20178:35 amRNSHolding(s) in Company
22nd Jun 201712:00 pmRNSSale and Leaseback transaction
7th Jun 20177:00 amRNSSale & Leaseback Transaction
2nd Jun 20173:00 pmRNSDirector/PDMR Shareholding
30th May 20175:55 pmRNSHolding(s) in Company -
26th May 201710:10 amRNSHolding(s) in Company
26th May 20178:56 amRNSTotal Voting Rights
26th May 20177:00 amRNSDirector/PDMR Shareholding
18th May 20177:00 amRNSAcquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.